HOME >> BIOLOGY >> NEWS
Academy honors 15 for major contributions to science

evenson Professor of International Politics, department of political science, Columbia University, New York City. Jervis was chosen "for showing, scientifically and in policy terms, how cognitive psychology, politically contextualized, can illuminate strategies for the avoidance of nuclear war." The award was established by a gift of William and Katherine Estes and has been presented since 1990.

NAS AWARD IN CHEMICAL SCIENCES a medal and prize of $15,000 awarded annually for innovative research in the chemical sciences that, in the broadest sense, contributes to the better understanding of the natural sciences and to the benefit of humanity goes to SAMUEL J. DANISHEFSKY, Eugene W. Kettering Chair and director, laboratory for bioorganic chemistry, Memorial Sloan-Kettering Cancer Center; and professor of chemistry, Columbia University, New York City. Danishefsky was chosen "for his wide-ranging accomplishments in natural products total synthesis and for his pioneering chemical synthesis of carbohydrates for the development of anticancer vaccines." The award, supported by The Merck Company Foundation, has been presented since 1979.

NAS AWARD FOR INITIATIVES IN RESEARCH a prize of $15,000 awarded annually to recognize innovative young scientists and to encourage research likely to lead toward new capabilities for human benefit (condensed matter/material science in 2006) goes to DAVID GOLDHABER-GORDON, deputy director of the NSF-Stanford-IBM Center for Probing the Nanoscale and assistant professor of physics, department of physics, Stanford University, Stanford, Calif. Goldhaber-Gordon was chosen "for his fundamental studies of electron correlations in mesoscopic structures." The award, presented since 1981, was established by AT&T Bell Laboratories in honor of William O. Baker and is supported by Lucent Technologies.

NAS AWARD IN MOLECULAR BIOLOGY a medal and prize of $25,000 awarded annually for a recent notable disc
'"/>


18-Jan-2006


Page: 1 2 3 4 5

Related biology news :

1. University of Arizona neurobiologist John Hildebrand elected to the National Academy of Sciences
2. Dr. Michael Petrides: Elected to the American Academy of Arts and Sciences
3. Einsteins Dr. Vern Schramm elected to the National Academy of Sciences
4. 5 Stanford professors elected to National Academy of Sciences
5. National Academy of Sciences elects 2 Rutgers professors
6. Salk scientist Ursula Bellugi elected to National Academy of Sciences
7. National Academy of Sciences elects 2 Brandeis University scientists to membership
8. Psychology professor elected to American Academy of Arts and Sciences
9. Academy paleontologist and Alaska artist in line for natural history awards
10. National Academy of Engineering announces winners of $1M challenge
11. Academy honors 18 for major contributions to science

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Academy honors for major contributions science

(Date:4/10/2015)... Research and Markets ( http://www.researchandmarkets.com/research/cjk4gb/security ... Competitive Profiles - NEC" report to their offering. ... will continue to supply a range of IT security ... company focus on the development of a Big Data ... in the Asia-Pacific region is ...
(Date:4/8/2015)... , April 8, 2015  Infinisource, a ... and services, and Morpho, a leading supplier of ... to produce the market,s most advanced biometrically-enabled time ... iSolved NXG time clock is setting a bold, ... labor data for the small and mid-size employer. ...
(Date:4/2/2015)... 2, 2015 In the ... far outperforms the strongest competitors, showing outstanding performance ... the system is capable of a throughput of ... up to be ten times faster than most ... performance.      (Photo: http://photos.prnewswire.com/prnh/20150402/738673-a ...
Breaking Biology News(10 mins):NEC Security Competitive Profile 2015 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3
(Date:4/16/2015)... (PRWEB) April 16, 2015 Regis Technologies ... American Association for Cancer Research (AACR) annual meeting. Regis ... Convention Center, starting Saturday, April 18, in Philadelphia and ... claim to title of the oldest and largest organization ... fellowships and grants, and partners with survivors to promote ...
(Date:4/16/2015)... (PRWEB) April 16, 2015 ... at Charlotte (UNC Charlotte) spin-out company, announced today ... Cooper, Ph.D., M.D., as Chief Operating Officer (COO). ... of experience in developing clinical diagnostic and biotechnology ... infectious disease. , Cooper’s extensive career transcends the ...
(Date:4/16/2015)... 16, 2015  In recognition of World Hemophilia Day, ... groups to illuminate more than 15 prominent landmarks red throughout ... Boston,s Zakim Bridge and Prudential Tower, ... Mercedes-Benz Superdome and Denver,s ... of April 17, and coincide with hemophilia community events in ...
(Date:4/16/2015)... April 16, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: ... U.S. joint venture with G-treeBNT (ReGenTree LLC) has ... clinical trial for the orphan disorder, neurotrophic keratopathy ... dry eye syndrome (DES) in the U.S.  Both ... RGN-259/GBT201, this year.  Each of these eye disorders ...
Breaking Biology Technology:Regis Technologies Joins American Association for Cancer Research Annual Meeting 2OncoTAb Names Dr. David L. Cooper as COO 2Biogen Shines A Light On Hemophilia Community By Illuminating U.S. Landmarks Red On World Hemophlia Day 2Biogen Shines A Light On Hemophilia Community By Illuminating U.S. Landmarks Red On World Hemophlia Day 3Biogen Shines A Light On Hemophilia Community By Illuminating U.S. Landmarks Red On World Hemophlia Day 4RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 3RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 4RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 5
Cached News: